D-Index & Metrics Best Publications

Gregory W. Albers

Stanford University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 126 Citations 78,264 628 World Ranking 1643 National Ranking 971

Overview

What is he best known for?

The fields of study Gregory W. Albers is best known for:

Myocardial infarction
Magnetic resonance imaging
Ischemia

Warfarin is connected with Aspirin and Antithrombotic in his research. He performs multidisciplinary study on Aspirin and Warfarin in his works. His work in Antithrombotic is not limited to one particular discipline; it also encompasses Cardiology. Cardiology connects with themes related to Ischemic stroke in his study. His Stroke (engine) study frequently draws connections to other fields, such as Mechanical engineering. Gregory W. Albers regularly ties together related areas like Stroke (engine) in his Mechanical engineering studies. He undertakes multidisciplinary studies into Magnetic resonance imaging and Hyperintensity in his work. He regularly links together related areas like Internal carotid artery in his Radiology studies. His study brings together the fields of Radiology and Internal carotid artery.

His most cited work include:

A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke (1050 citations)
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm (482 citations)
Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke (463 citations)

What are the main themes of his work throughout his whole career to date

Within the field of Diffusion MRI and Effective diffusion coefficient Gregory W. Albers studies Magnetic resonance imaging. His Pathology study frequently draws connections between adjacent fields such as Alternative medicine and Lesion. He frequently studies issues relating to Pathology and Alternative medicine. With his scientific publications, his incorporates both Lesion and Magnetic resonance imaging. His work on Mechanical engineering expands to the thematically related Stroke (engine). Mechanical engineering is often connected to Stroke (engine) in his work. Much of his study explores Internal medicine relationship to Confidence interval. His Confidence interval study often links to related topics such as Internal medicine. His Cardiology study often links to related topics such as Embolism.

Gregory W. Albers most often published in these fields:

Stroke (engine) (83.33%)
Mechanical engineering (80.95%)
Internal medicine (71.43%)

What were the highlights of his more recent work (between 2012-2021)?

Internal medicine (100.00%)
Stroke (engine) (100.00%)
Mechanical engineering (100.00%)

In recent works Gregory W. Albers was focusing on the following fields of study:

Internal medicine connects with themes related to Transcranial Doppler in his study. His Internal medicine research extends to Transcranial Doppler, which is thematically connected. His Mechanical engineering research extends to Stroke (engine), which is thematically connected. His Mechanical engineering study frequently involves adjacent topics like Stroke (engine). Gregory W. Albers combines Randomized controlled trial and Clinical endpoint in his studies. Gregory W. Albers performs multidisciplinary study in the fields of Clinical endpoint and Randomized controlled trial via his papers. He conducts interdisciplinary study in the fields of Clinical trial and Randomization through his research. He integrates Randomization and Clinical trial in his research. Gregory W. Albers carries out multidisciplinary research, doing studies in Ischemia and Reperfusion therapy.

Between 2012 and 2021, his most popular works were:

NeuroThera® Efficacy and Safety Trial – 3 (NEST-3): A Double-Blind, Randomized, Sham-Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy with the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke within 24 h of Stroke Onset (26 citations)
Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm (20 citations)
Tissue at Risk and Ischemic Core Estimation Using Deep Learning in Acute Stroke (14 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke

Jeffrey L. Saver;Mayank Goyal;Alain Bonafe;Hans Christoph Diener.
The New England Journal of Medicine (2015)

4639 Citations

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

Werner Hacke;Geoffrey Donnan;Cesare Fieschi;Markku Kaste.
The Lancet (2004)

3552 Citations

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

Gregory W. Albers;Michael P. Marks;Stephanie Kemp;Soren Christensen.
The New England Journal of Medicine (2018)

3092 Citations

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Kennedy R Lees;Erich Bluhmki;Rüdiger von Kummer;Thomas G Brott.
The Lancet (2010)

2457 Citations

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell.
The Lancet (2014)

2325 Citations

Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease

J. Donald Easton;Jeffrey L. Saver;Gregory W. Albers;Mark J. Alberts.
Stroke (2009)

1999 Citations

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

Karen L. Furie;Scott E. Kasner;Robert J. Adams;Gregory W. Albers.
Stroke (2011)

1854 Citations

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Wayne M. Clark;Stanley Wissman;Gregory W. Albers;Jack H. Jhamandas.
JAMA (1999)

1628 Citations

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

J.P. Mohr;J.L.P. Thompson;Ronald M. Lazar;Bruce Levin.
The New England Journal of Medicine (2001)

1479 Citations

Transient Ischemic Attack — Proposal for a New Definition

Gregory W. Albers;Louis R. Caplan;J. Donald Easton;Pierre B. Fayad.
The New England Journal of Medicine (2002)

1468 Citations

If you think any of the details on this page are incorrect, let us know.